Perez-Gutthann S, de Abajo F, Garcia Rodriguez LA, Varas-Lorenzo C, Gutierrez L, Castellsague J. Pharmacoepidemiology: Epidemiology applied to pharmaceutical development, safety and risk. In: Hernández G, Moreno A, Zaragoza F, Porras A, editors. MEDIPHARM: Tratado de Medicina Farmacéutica. Madrid: Spain. Médica Panamericana; 2010.
Varas-Lorenzo C, Rodriguez LA, Maguire A, Castellsague J, Perez-Gutthann S. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis. 2007 Jun;192(2):376-83.
Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol Drug Saf. 2007 Apr 1;16(4):366-76.
Arana A, Gutierrez L, Garcia-Rodriguez LA, Perez-Gutthann S. Antiepileptics and liver, testes, cervix uteri and vulvar cancer: a cohort study. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 2001. Toronto, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2001 Aug; 10(supp 1):128.
Varas-Lorenzo C, Perez-Gutthann S, Castellsague J, Gutierrez LP. Effects of transdermal hormone replacement therapy on cardiovascular outcomes: epidemiological evidence. In: Genazzani AR, editors. Hormone replacement therapy and cardiovascular disease. New York: United States. The Partenon Publishing Group Limited; 2001.
Perez GS, Garcia Rodriguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology. 1993 Nov 1;4(6):496-501.
Derby LE, Gutthann SP, Jick H, Dean AD. Liver disorders in patients receiving chlorpromazine or isoniazid. Pharmacotherapy. 1993 Jul 1;13(4):353-8.